Oct 24, 2026 04:15AM
Oct 23, 2026 10:16AM
Oct 16, 2026 06:23AM
Aug 25, 2026 10:40AM
Aug 25, 2026 10:40AM
Aug 5, 2026 06:00AM
Jun 12, 2026 06:00AM BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026
Jun 1, 2026 06:00AM
May 29, 2026 06:00AM
May 27, 2026 05:00PM
May 27, 2026 05:00PM
May 21, 2026 06:00AM
May 13, 2026 01:28PM
May 13, 2026 01:27PM BeOne Medicines’ BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma
May 6, 2026 06:00AM
Apr 29, 2026 06:00AM
Apr 29, 2026 06:00AM
Feb 26, 2026 06:00AM
Jan 6, 2026 01:31PM
Jan 6, 2026 01:30PM
Dec 18, 2025 06:00AM BeOne Medicines receives FDA fast track status for liver cancer drug
Dec 18, 2025 06:00AM
Dec 8, 2025 08:00AM
Dec 7, 2025 06:00PM
Nov 26, 2025 06:00AM
Nov 26, 2025 06:00AM
Nov 20, 2025 06:00AM
Nov 6, 2025 06:00AM BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates
Oct 13, 2025 06:00AM
Oct 13, 2025 06:00AM
Sep 29, 2025 08:30AM
Sep 11, 2025 08:18AM
Aug 29, 2025 06:00AM
Aug 29, 2025 06:00AM
Aug 11, 2025 04:56PM Oncolytics Biotech shareholders elect eight directors at annual meeting
Aug 11, 2025 04:55PM
Aug 8, 2025 09:05AM
Aug 8, 2025 09:00AM
Aug 8, 2025 09:00AM
Aug 6, 2025 06:00AM
Aug 5, 2025 08:30AM
Jul 31, 2025 06:01AM BeOne Medicines gets EU PRIME designation for blood cancer drug
Jul 31, 2025 06:00AM
Jul 29, 2025 08:30AM
Jul 29, 2025 08:30AM
Jul 23, 2025 09:39AM
Jul 22, 2025 03:33PM
Jul 22, 2025 03:32PM
Jul 16, 2025 08:30AM Oncolytics Biotech® Presents Aggregated Translational Data Providing Evidence of Pelareorep's Effectiveness Across Multiple Tumor Types
Jul 10, 2025 08:30AM

335,219 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All